Members Stories

December 11, 2014 12:00 am
By Jim Omel Grand Island, NE@IMFjimMyeloma It is interesting that my favorite moment at the 56th American Society of Hematology (ASH) Annual Meeting corresponds quite directly with my least favorite moment. Myeloma therapy has undergone an...
December 8, 2014 12:00 am
By Jim Omel Grand Island, NE@IMFjimMyeloma Myeloma is an incredibly complex genomic disease. Gene alterations can cause cell metabolic pathways to become activated or silenced. If pathway activation causes an oncogene (tumor promoter) to become...
December 7, 2014 8:50 am
By Jim Omel Grand Island, NE@IMFjimMyeloma Excitement of support group leaders (SGLs) at the 56th American Society of Hematology (ASH) Annual Meeting and tremendous progress against myeloma come together in oral presentations, posters, and...
December 1, 2014 8:48 am
by Jim Omel Grand Island, NE@IMFjimMYELOMA The American Society of Hematology (ASH) Annual Meeting is by far the most exciting meeting of the year for those of us with myeloma. Clinical trials are updated, new drugs are discussed, and...